- Man or nonlactating and nonpregnant woman, aged 18 to 70 years, inclusive, at the
screening visit.
- Diagnosis of systemic lupus erythematosus more than 6 months before study day 1.
- History of positive antinuclear antibody titer of >1:160 or equivalent.
- Biopsy-proven class V lupus nephritis within the last 2 years.
- Have been on a stable dose of oral corticosteroids ( equivalent) for 2 months before study day 1.
- Man or nonlactating and nonpregnant woman, aged 18 to 70 years, inclusive, at the
screening visit.
- Diagnosis of systemic lupus erythematosus more than 6 months before study day 1.
- History of positive antinuclear antibody titer of >1:160 or equivalent.
- Biopsy-proven class V lupus nephritis within the last 2 years.
- Have been on a stable dose of oral corticosteroids ( equivalent) for 2 months before study day 1.